130 related articles for article (PubMed ID: 7466730)
21. Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride.
Witztum JL; Jacobs LS; Schonfeld G
J Clin Endocrinol Metab; 1978 May; 46(5):838-40. PubMed ID: 262768
[TBL] [Abstract][Full Text] [Related]
22. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
Harvengt C; Desager JP
Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
[TBL] [Abstract][Full Text] [Related]
23. Results of colestipol therapy in Type II hyperlipoproteinemia.
Lees AM; McCluskey MA; Lees RS
Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181
[TBL] [Abstract][Full Text] [Related]
24. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
Kuo PT; Hayase K; Kostis JB; Moreyra AE
Circulation; 1979 Feb; 59(2):199-211. PubMed ID: 215338
[TBL] [Abstract][Full Text] [Related]
25. Regression of coronary atherosclerosis in man.
Myant NB
Adv Exp Med Biol; 1984; 168():139-52. PubMed ID: 6375296
[No Abstract] [Full Text] [Related]
26. [Long-term effects of a glycosaminoglycan on plasma lipids].
Avogaro P; Bittolo-Bon G; Alessandrini P
Clin Ter; 1981 Jul; 98(1):47-61. PubMed ID: 7249572
[No Abstract] [Full Text] [Related]
27. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
Sundberg EE; Illingworth DR
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
[TBL] [Abstract][Full Text] [Related]
28. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia.
Lowe GD; Drummond MM; Third JL; Bremner WF; Forbes CD; Prentice CR; Lawrie TD
Thromb Haemost; 1980 Feb; 42(5):1503-7. PubMed ID: 7368154
[TBL] [Abstract][Full Text] [Related]
29. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol.
Schwarz KB; Goldstein PD; Witztum JL; Schonfeld G
Pediatrics; 1980 Feb; 65(2):243-50. PubMed ID: 7354970
[TBL] [Abstract][Full Text] [Related]
30. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
[No Abstract] [Full Text] [Related]
31. [Etiroxate treatment for hyperlipoproteinaemia type IIa and IIb (author's transl)].
Zadák Z; Kalinová M; Sobotka L
Cas Lek Cesk; 1982 May; 121(19):593-5. PubMed ID: 7093991
[No Abstract] [Full Text] [Related]
32. Colestipol hydrochloride for treatment of hypercholesterolemia in a family practice: five-year study.
Ruoff G
J Am Geriatr Soc; 1978 Mar; 26(3):121-6. PubMed ID: 624819
[TBL] [Abstract][Full Text] [Related]
33. [Type II hyperlipoproteinaemia treated with etiroxate (author's transl)].
Vondra K; Válek J; Dobiásová M; Honzák R
Cas Lek Cesk; 1979 Oct; 118(40-41):1251-5. PubMed ID: 527004
[No Abstract] [Full Text] [Related]
34. Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid.
Kuo PT; Toole JF; Schaaf JA; Jones A; Wilson AC; Kostis JB; Moreyra AE
Stroke; 1987; 18(4):716-21. PubMed ID: 3299882
[TBL] [Abstract][Full Text] [Related]
35. [Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration].
Andĕl M; Brodan V; Kucerová L; Grafnetter D; Kuhn E; Veselková A
Cas Lek Cesk; 1980 May; 119(22):616-21. PubMed ID: 7427980
[No Abstract] [Full Text] [Related]
36. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.
Dorr AE; Gundersen K; Schneider JC; Spencer TW; Martin WB
J Chronic Dis; 1978 Jan; 31(1):5-14. PubMed ID: 346598
[No Abstract] [Full Text] [Related]
37. Clinical study on the effect of simvastatin on butyrylcholinesterase activity.
Muacević-Kataneca D; Bradamante V; Reinec Z; Sucić M; Poljicanin T; Busljeta I; Metelko Z
Arzneimittelforschung; 2005; 55(5):271-5. PubMed ID: 15960426
[TBL] [Abstract][Full Text] [Related]
38. [Colestipol by hypercholesteremia in diabetics].
Düntsch G
Fortschr Med; 1977 Jun; 95(22):1492-6. PubMed ID: 873435
[TBL] [Abstract][Full Text] [Related]
39. Response of hyperlipoproteinemia to colestipol.
Sachs BA; Wolfman L
N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
[No Abstract] [Full Text] [Related]
40. Cholesterol-lowering effect of colestipol hydrochloride given twice daily in hypercholesterolemic patients.
Gundersen K; Cooper EE; Ruoff G; Nikolai T; Assenzo JR
Atherosclerosis; 1976; 25(2-3):303-10. PubMed ID: 795441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
